Using skin models to assess the effects of a protection cream on skin barrier function

被引:15
作者
zur Mühlen, A
Klotz, A
Weimans, S
Veeger, M
Thörner, B
Diener, B
Hermann, M
机构
[1] Degussa AG, Stoko Skin Care, DE-47805 Krefeld, Germany
[2] Degussa AG, Serv Krefeld, Lab Toxicol & Ecol, DE-47805 Krefeld, Germany
关键词
in vitro testing; three-dimensional skin models; skin protection; in vivo testing; skin barrier function; skin lipids;
D O I
10.1159/000078819
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: There is a basic necessity to understand the mechanisms of the protective effects of emulsions. This would promote the development of protective cosmetics and therefore improve the prevention and treatment of occupational skin diseases. However, for such studies, no reliable skin model is available. Objective: An in vitro skin model test was developed to evaluate the protective mechanism of cosmetic ingredients. Methods: The efficacy of three products was assessed by an in vivo test ( Repetitive Occlusive Irritation Test) and then 3-dimensional skin model tests were carried out. Results: In vivo test results demonstrate that the best protection against sodium dodecyl sulphate is offered by a multiple emulsion. In the case of a skin model test, sodium dodecyl sulphate led to cell damage, an increase in pro-inflammatory markers and some barrier lipids. The multiple emulsion increased the content of skin lipids, without inducing irritation or cell death. Conclusion: Skin models react similarly to sodium dodecyl sulphate compared to human skin and therefore they are suitable to study barrier repair after sodium dodecyl sulphate damage. It is likely that the superior protective effect of the multiple emulsion in vivo is based on the increased amount of skin barrier lipids. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:167 / 175
页数:9
相关论文
共 39 条
[21]   Sphingolipid signaling in epidermal homeostasis - Current knowledge and new therapeutic approaches in dermatology [J].
Geilen, CC ;
Barz, S ;
Bektas, M .
SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY, 2001, 14 (05) :261-271
[22]  
GREIF C, 2000, DERM CLIN BAS SCI, P323
[23]  
KLOTZ A, 2002, BG, P460
[24]   Occupational skin-protection products - a review [J].
Kresken, J ;
Klotz, A .
INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH, 2003, 76 (05) :355-358
[25]   Effect of a lipid-rich emollient containing ceramide 3 in experimentally induced skin barrier dysfunction [J].
Kucharekova, M ;
Schalkwijk, J ;
Van de Kerkhof, PCM ;
Van de Valk, PGM .
CONTACT DERMATITIS, 2002, 46 (06) :331-338
[26]   Arachidonic acid metabolism in primary irritant dermatitis produced by patch testing of human skin with surfactants [J].
Müller-Decker, K ;
Heinzelmann, T ;
Fürstenberger, G ;
Kecskes, A ;
Lehmann, WD ;
Marks, F .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1998, 153 (01) :59-67
[27]   Comparison of in vitro and in vivo human skin responses to consumer products and ingredients with a range of irritancy potential [J].
Perkins, MA ;
Osborne, R ;
Rana, FR ;
Ghassemi, A ;
Robinson, MK .
TOXICOLOGICAL SCIENCES, 1999, 48 (02) :218-229
[28]   GUIDELINES FOR TRANSEPIDERMAL WATER-LOSS (TEWL) MEASUREMENT - A REPORT FROM THE STANDARDIZATION-GROUP-OF-THE EUROPEAN-SOCIETY-OF-CONTACT-DERMATITIS [J].
PINNAGODA, J ;
TUPKER, RA ;
AGNER, T ;
SERUP, J .
CONTACT DERMATITIS, 1990, 22 (03) :164-178
[29]   Characterization of reconstructed skin models [J].
Ponec, M ;
Boelsma, E ;
Gibbs, S ;
Mommaas, M .
SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY, 2002, 15 :4-17
[30]   The formation of competent barrier lipids in reconstructed human epidermis requires the presence of vitamin C [J].
Ponec, M ;
Weerheim, A ;
Kempenaar, J ;
Mulder, A ;
Gooris, GS ;
Bouwstra, J ;
Mommaas, AM .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (03) :348-355